Drugs / PF 05212389
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01472848 Comparator | Apr → Jul 2011 | obesity disorder | Pfizer | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF 05212389 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01472848 ↗ |
| Route | Subcutaneous | “QD SC administration of PF 05212389 (12 subjects)” NCT01472848 ↗ |